(A) GINIP is expressed in cortical neuron cultures. Neuron cultures established from the cortices of neonatal mouse brains were analyzed by immunoblotting (IB) on the indicated days in vitro (DIV). n=2.
(B) GINIP is not expressed in cortical glial cultures. Neuron and glial cultures established from the cortices of neonatal mouse brains were analyzed by immunoblotting (IB) on DIV12. n=3.
(C) GINIP is expressed in cortical neurons but not in glia. GINIP was co-stained with NeuN or GFAP in DIV12 cortical cultures. Arrows indicate NeuN+ or GFAP+ cells. The proportion of GINIP+ in NeuN+ or GFAP+ cells was quantified from three independent cultures (two image fields per experiment). Mean±S.E.M. Scale bar = 20 μm.
(D, E) Loss of GINIP decreases Gβγ responses triggered by GABABR (D) and α2-AR (E). BRET was measured in DIV12–14 cortical neurons from GINIP flox/flox mice that had been transduced (red) or not (black) with AAV-Cre. BRET responses were normalized to the maximum response of WT in each experiment. Mean±S.E.M., n=8–9. **p<0.01, ***p<0.001, ****p<0.0001, paired t-test.
(F) Loss of GINIP does not affect Gβγ responses triggered by β-AR. BRET was measured in DIV12–14 cortical neurons as in D and E. Mean±S.E.M. n=5
(G) Loss of GINIP enhances the inhibition of adenylyl cyclase upon stimulation of GABABR. cAMP was measured by BRET in DIV16–18 cortical neurons from GINIP flox/flox mice that had been transduced (red) or not (black) with AAV-Cre. Dotted lines in the kinetic traces indicate controls not stimulated with baclofen. Mean±S.E.M., n=9. *p<0.05, ****p<0.0001, paired t-test.
See also Figure S5